Calendar Altimmune, Inc.

Equities

ALT

US02155H2004

Market Closed - Nasdaq 16:00:00 2024-06-18 EDT 5-day change 1st Jan Change
5.91 USD -0.17% Intraday chart for Altimmune, Inc. -8.80% -47.47%

Chart calendar Altimmune, Inc.

bc57fcff9a05d61ad96023123b72c.PA3_kdPt2OOigD2QI8bEQK4gdItoh97u3P1d41hP6eM.aFfP2r-jrtraxQ-oe7ylOMJNG8gHxLWImbwShGo_pqtMPc3Uuq6MiZLqfA~9049f6dd3356158f4a6dfb543ac1ceda

Upcoming events on Altimmune, Inc.

2024-06-22 16:45 American Diabetes Association Scientific Conference
2024-06-23 13:45 American Diabetes Association Scientific Conference
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-04 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)
2025-05-19 Q1 2025 Earnings Release (Projected)

Past events on Altimmune, Inc.

2024-06-12 09:20 Goldman Sachs Global Healthcare Conference - Fireside Chat
2024-06-05 14:00 Jefferies Global Healthcare Conference
2024-06-05 02:30 European Association for the Study of the Liver Congress - Abstract Number: 3002
2024-06-05 02:30 European Association for the Study of the Liver Congress - Abstract Number: 2985
2024-06-05 02:30 European Association for the Study of the Liver Congress - Abstract Number: 2881
2024-05-23 10:00 UBS Obesity Therapeutics Day
2024-05-16 13:30 GLP-1 Based Therapeutics Summit - Attaining Product Differentiation through Improved Patient Segment
2024-05-15 10:00 GLP-1 Based Therapeutics Summit - Focusing on the Use of GLP-1s in Treating MASH & Fatty Liver Disea
2024-05-14 09:00 Citizens JMP Life Sciences Conference
2024-05-09 08:30 Q1 2024 Earnings Call
2024-05-09 07:00 Q1 2024 Earnings Release
2024-05-08 16:00 BTIG Obesity Health Forum
2024-04-02 13:52 Investor Meeting - Jefferies
2024-03-27 08:30 Q4 2023 Earnings Call
2024-03-27 07:00 Q4 2023 Earnings Release
2024-01-05 NASH-TAG Conference - Abstract No: #51
2023-12-01 08:30 MOMENTUM Phase 2 Trial Results Call
2023-11-07 08:30 Q3 2023 Earnings Call
2023-11-07 07:00 Q3 2023 Earnings Release
2023-10-25 15:00 H.C. Wainwright NASH Investor Conference - Fireside Chat

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
5,80
5,98
-2.92%
8,19
7,71
6.13%
4,41
1,18
274.08%
-0,07
0,05
-241.67%
0,43
0,34
24.04%

31,3

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-96,4
-92,2
-4.51%
-87,9
-89,3
1.53%
0,00
-83,1
-

-95,4

EBIT
Million USD
Released
Forecast
Spread
-21,5
-21,3
-0.68%
-54,8
-70,4
22.11%
-85,5
-97,5
12.28%
-87,7
-91,4
3.99%
-83,5
-93,9
11.09%

-61,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-20,6
-20,4
-0.68%
-54,5
-69,9
22.08%
-97,1
-99,3
2.24%
-84,9
-91,2
6.88%
-88,4
-81,2
-8.96%

-49,1

Net income
Million USD
Released
Forecast
Spread
-20,5
-20,4
-0.69%
-49,0
-64,3
23.74%
-97,1
-98,7
1.64%
-84,7
-90,9
6.82%
-88,4
-81,1
-9.1%

-59,1

EPS
USD
Released
Forecast
Spread
-1,60
-1,52
-5.26%
-1,91
-2,59
26.3%
-2,35
-2,41
2.62%
-1,81
-2,04
11.09%
-1,66
-1,47
-13.18%

-0,84

Announcement Date27/03/2025/02/2115/03/2228/02/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,03
0,88
-96.38%
0,01
0,87
-99.08%
0,00
1,04
-99.81%
-0,11
0,03
-423.53%
0,02
0,00
-
0,01
0,00
100%
0,36
0,00
41993.02%
0,04
0,00
1628.97%
0,01
0,00
-

0,00


31,3


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread
-19,4
-17,9
-8.27%
-20,3
-20,9
2.67%
-24,9
-23,9
-4.15%
-23,3
-24,8
6.18%
-21,4
-23,9
10.45%
-17,5
-21,7
19.35%
-22,0
-18,1
-21.48%

-19,4

-26,7
-21,8
-22.42%

-19,9


-20,4


-20,9







EBIT
Million USD
Released
Forecast
Spread
-19,5
-24,1
19.1%
-20,4
-22,5
9.36%
-24,8
-23,8
-3.97%
-23,1
-26,3
12.07%
-21,8
-24,8
12.15%
-18,0
-24,3
25.94%
-22,5
-22,6
0.37%
-21,2
-34,9
39.23%
-26,8
-23,7
-13.28%

-25,2


15,3


-25,1


-28,2


-32,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-19,4
-24,1
19.38%
-20,1
-21,5
6.48%
-23,7
-23,8
0.4%
-21,7
-27,1
20.2%
-20,1
-24,6
18.35%
-16,1
-23,5
31.54%
-20,7
-21,6
4.4%
-31,6
-24,4
-29.94%
-24,4
-22,9
-6.37%

-24,2


24,4


-24,5


-25,7


-30,4

Net income
Million USD
Released
Forecast
Spread
-19,4
-24,1
19.38%
-20,1
-21,8
7.82%
-23,5
-23,4
-0.51%
-21,7
-27,1
19.97%
-20,1
-24,5
18.02%
-16,1
-16,3
1.52%
-20,7
-21,5
3.79%
-31,6
-24,3
-30.25%
-24,4
-22,8
-7.1%

-24,8


15,6


-25,3


-25,7


-30,4

EPS
USD
Released
Forecast
Spread
-0,44
-0,59
24.79%
-0,42
-0,50
15.15%
-0,48
-0,49
2.83%
-0,44
-0,54
18.22%
-0,40
-0,48
16.67%
-0,32
-0,45
29.41%
-0,39
-0,42
6.4%
-0,54
-0,38
-44%
-0,34
-0,36
5.99%

-0,35


0,19


-0,35


-0,34


-0,35

Announcement Date12/05/2211/08/2210/11/2228/02/2311/05/2310/08/2307/11/2327/03/2409/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALT Stock
  4. Calendar Altimmune, Inc.